|Last Price$100.34||Day Change (%)0.20%|
|Open Price$100.28||Day Change ($)0.20|
|Day Range100.15–100.95||52-Week Range95.10–109.49|
As of Fri 3/27/2015 7:15:00 PM | USD
Research and Markets: India Coronary Stents Market - Potential & Growth Forecast to 2019
Johnson & Johnson CEO's pay rises 48%
Johnson & Johnson Announces Strategic Investment Alliance to Combat Dementia Globally
J & J's McNeil Settles Probe for $25 Million
Johnson & Johnson Near Deal for Drugmaker Pharmacyclics -FT
Berkshire joins forces with 3G Capital to facilitate merger.
These top managers continue to focus on higher-quality dividend-paying stocks in a market that has become more volatile of late.
Johnson & Johnson near deal for Pharmacyclics: FT
Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.
Cash piles, activists push stock buybacks to near record levels